Latest News about Exclusives
Recent news which mentions Exclusives
EXCLUSIVE: MIRA Pharmaceuticals Files FDA Application To Start Human Trials For Its Lead Pain Treatment
December 19, 2024
From Benzinga
EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia
December 19, 2024
From Benzinga
Who's Next To Join Tesla, Broadcom In $1 Trillion Club? Over 50% Say The World's Biggest Retailer
December 18, 2024
From Benzinga
The $133 Billion Question: Can Stablecoins Streamline Trade Settlements?
December 18, 2024
From Benzinga
Why TradFi Firms Have 'No Choice' But To Enter Crypto As M&A, Regulations Drive Change
December 18, 2024
From Benzinga
From Benzinga
EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend
December 18, 2024
From Benzinga
EXCLUSIVE: Leveraged ETFs Offer Short-Term Edge As Traders Eye Semiconductors, China, And Quantum Tech In Post-Election Market
December 17, 2024
From Benzinga
'Most Crypto-Foward' RIA Slams Bitcoin Forecasts From Michael Saylor, Others: 'Disvalues It To Me'
December 16, 2024
From Benzinga
From Benzinga
EXCLUSIVE: Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer
December 16, 2024
From Benzinga
EXCLUSIVE: Trinity Capital Commits $50 Million In Equipment Financing To Form Energy
December 16, 2024
From Benzinga
EXCLUSIVE: Eric Trump Declares Bitcoin The Future, Details Tax-Free Crypto Goals For Trump Presidency
December 15, 2024
From Benzinga
EXCLUSIVE: Eric Trump Calls Elon Musk 'Albert Einstein Of Our Time,' Says Tesla CEO Will Help Build 'A Stronger America'
December 14, 2024
Tickers
NEWS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free